[DPHARMA] YoY Annualized Quarter Result on 30-Jun-2009 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Aug-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Jun-2009 [#2]
Profit Trend
QoQ- 10.78%
YoY- 1.11%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Revenue 140,824 136,658 129,554 123,456 121,954 111,608 109,814 4.22%
PBT 35,812 34,332 33,164 40,674 41,260 42,668 41,834 -2.55%
Tax -8,662 -8,620 -8,292 -9,754 -10,678 -11,684 -11,092 -4.03%
NP 27,150 25,712 24,872 30,920 30,582 30,984 30,742 -2.04%
-
NP to SH 27,150 25,712 24,872 30,920 30,582 30,984 30,742 -2.04%
-
Tax Rate 24.19% 25.11% 25.00% 23.98% 25.88% 27.38% 26.51% -
Total Cost 113,674 110,946 104,682 92,536 91,372 80,624 79,072 6.23%
-
Net Worth 162,400 154,105 140,182 136,003 129,043 145,758 139,356 2.58%
Dividend
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Div 9,716 9,718 12,491 166 22,201 - 19,509 -10.95%
Div Payout % 35.79% 37.80% 50.22% 0.54% 72.60% - 63.46% -
Equity
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Net Worth 162,400 154,105 140,182 136,003 129,043 145,758 139,356 2.58%
NOSH 138,803 138,833 138,794 138,779 138,756 138,817 139,356 -0.06%
Ratio Analysis
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
NP Margin 19.28% 18.81% 19.20% 25.05% 25.08% 27.76% 27.99% -
ROE 16.72% 16.68% 17.74% 22.73% 23.70% 21.26% 22.06% -
Per Share
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
RPS 101.46 98.43 93.34 88.96 87.89 80.40 78.80 4.29%
EPS 19.56 18.52 17.92 22.28 22.04 22.32 22.06 -1.98%
DPS 7.00 7.00 9.00 0.12 16.00 0.00 14.00 -10.90%
NAPS 1.17 1.11 1.01 0.98 0.93 1.05 1.00 2.64%
Adjusted Per Share Value based on latest NOSH - 138,837
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
RPS 14.64 14.21 13.47 12.83 12.68 11.60 11.42 4.22%
EPS 2.82 2.67 2.59 3.21 3.18 3.22 3.20 -2.08%
DPS 1.01 1.01 1.30 0.02 2.31 0.00 2.03 -10.97%
NAPS 0.1688 0.1602 0.1457 0.1414 0.1341 0.1515 0.1449 2.57%
Price Multiplier on Financial Quarter End Date
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Date 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 29/06/07 30/06/06 -
Price 2.23 2.34 2.45 2.13 2.48 2.64 2.69 -
P/RPS 2.20 2.38 2.62 2.39 2.82 3.28 3.41 -7.03%
P/EPS 11.40 12.63 13.67 9.56 11.25 11.83 12.19 -1.10%
EY 8.77 7.91 7.31 10.46 8.89 8.45 8.20 1.12%
DY 3.14 2.99 3.67 0.06 6.45 0.00 5.20 -8.05%
P/NAPS 1.91 2.11 2.43 2.17 2.67 2.51 2.69 -5.54%
Price Multiplier on Announcement Date
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Date 16/08/12 18/08/11 24/08/10 26/08/09 26/08/08 23/08/07 23/08/06 -
Price 2.38 2.22 2.45 2.50 2.30 2.70 2.77 -
P/RPS 2.35 2.26 2.62 2.81 2.62 3.36 3.52 -6.50%
P/EPS 12.17 11.99 13.67 11.22 10.44 12.10 12.56 -0.52%
EY 8.22 8.34 7.31 8.91 9.58 8.27 7.96 0.53%
DY 2.94 3.15 3.67 0.05 6.96 0.00 5.05 -8.61%
P/NAPS 2.03 2.00 2.43 2.55 2.47 2.57 2.77 -5.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment